市场调查报告书
商品编码
1370645
气道清除设备市场规模,按设备类型(振盪式呼气正压、高频胸壁振盪)、按应用(慢性阻塞性肺部疾病、支气管扩张)、最终用途和预测,2023 - 2032 年Airway Clearance Devices Market Size By Device Type (Oscillatory Positive Expiratory Pressure, High Frequency Chest Wall Oscillation ), By Application (Chronic Obstructive Pulmonary Disease, Bronchiectasis), By End-use, & Forecast, 2023 - 2032 |
由于越来越多地采用便携式和用户友好型家庭呼吸护理设备,气道清除设备市场规模预计从 2023 年到 2032 年将以 5.2% 的复合年增长率扩大。最近,慢性呼吸系统疾病的负担不断增加,促使人们越来越偏好方便、舒适的治疗选择。此外,更高的技术进步导緻紧凑且易于使用的设备以及鼓励家庭护理的支持性医疗保健政策将进一步推动市场扩张。
对高频胸壁振盪和肺内衝击通气等新型机制的投资不断增加,加上产业参与者和研究机构之间不断加强的合作,也正在促进下一代气道清除设备的开发。举个例子,2023 年7 月,医疗科技公司Inogen Inc. 收购了总部位于法国的私人公司Physio-Assist SAS,以实现产品组合多元化,并扩大其在美国和欧洲、中东和非洲地区的产品供应,为慢性病患者提供服务。
气道清除设备市场分为设备类型、应用、最终用途和区域。
就设备类型而言,由于振盪式呼气正压 (OPEP) 领域在治疗各种呼吸系统疾病方面的功效,预计其行业价值将在 2023 年至 2032 年期间获得显着增长。慢性阻塞性肺病 (COPD) 和囊性纤维化的盛行率不断上升,推动了对非侵入性有效气道清除解决方案的需求。此外,对先进 OPEP 设备设计的日益青睐以及呼吸护理医疗支出的增加将有助于该细分市场的成长。
2023年至2032年间,气道清除装置市场可能会因慢性阻塞性肺病应用领域而出现显着增长。人口老龄化的加剧、环境污染的快速发展以及吸烟习惯的负担正在导致患有慢性阻塞性肺病的患者数量不断增加。此外,针对慢性阻塞性肺病患者需求的便携式和用户友好型设备的迅速进步将推动该细分市场的扩张。
从地区来看,由于呼吸系统疾病盛行率上升、肺部健康意识增强以及老年人口不断增长,亚太地区气道清除设备产业预计在 2023 年至 2032 年期间以复合年增长率显着扩张。技术进步、医疗基础设施发展以及政府支持呼吸照护的措施正在促进市场发展。此外,区域和国际参与者之间日益加强的合作以及对研发活动的更加重视将促进区域产业的成长。
Airway Clearance Devices Market size is anticipated to expand at 5.2% CAGR from 2023-2032, driven by the increasing adoption of portable and user-friendly devices for home-based respiratory care. Of late, the surging burden of chronic respiratory conditions is fueling the rising preference for convenient and comfortable treatment options. Moreover, the higher technological advancements leading to compact and easy-to-use devices along with supportive healthcare policies for encouraging home-based care will further propel the market expansion.
Rising investments in novel mechanisms, such as high-frequency chest wall oscillation and intrapulmonary percussive ventilation coupled with the increasing collaborations between industry players and research institutions are also fostering the development of next-generation airway clearance devices. To cite an instance, in July 2023, medical technology firm Inogen Inc. acquired Physio-Assist SAS, a privately held company headquartered in France to diversify its portfolio and expand its product offerings across the U.S. and EMEA to serve the chronic disease patients.
The airway clearance devices market is segmented into device type, application, end-use, and region.
With respect to device type, the industry value from the oscillatory positive expiratory pressure (OPEP) segment is estimated to gain significant traction from 2023-2032 owing to its efficacy in treating various respiratory conditions. The rising prevalence of chronic obstructive pulmonary disease (COPD) and cystic fibrosis is driving the demand for non-invasive and effective airway clearance solutions. Moreover, the surging preference for advanced OPEP device designs and increased healthcare expenditure on respiratory care will contribute to the segment growth.
Airway clearance devices market is likely to witness significant growth from the chronic obstructive pulmonary disease application segment between 2023 and 2032. The growing aging population, rapid rate of environmental pollution, and burden of smoking habits are leading to the increasing number of patients suffering from COPD. Additionally, the surging advancements in portable and user-friendly devices tailored to the needs of COPD patients will propel the segment expansion.
Regionally, the APAC airway clearance devices industry is set to expand at notable CAGR from 2023-2032 fueled by the rising prevalence of respiratory disorders, increasing awareness regarding pulmonary health, and the growing elderly population. The technological advancements, healthcare infrastructure developments, and government initiatives for supporting respiratory care are contributing to the market development. Additionally, the increasing collaborations between regional and international players along with the higher emphasis on R&D activities will bolster the regional industry growth.